Manufacturer record
Park Pharmaceuticals: regulatory record
Last checked 20 September 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
14 batches manufactured by Park Pharmaceuticals (Haryana) were declared Not of Standard Quality between May 2019 and June 2026. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Records by type
14 records linked to Park Pharmaceuticals in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Phenylephrine Hydrochloride & Chlorpheniramine Maleate Syrup IP | KKP-006Mfg 2025-02 · Exp 2027-01 | ContentOther | DTL, Madurai-19State lab | Jun 2026 |
| Amoxycillin & Potasium Clavulanate Tablets I.P. 625 mg | BRE-172Mfg 2025-07 · Exp 2026-12 | The sample does not conform to I.P. w.r.to the tests for DissolutionDissolution | SDTL, AssamState lab | Mar 2026 |
| Amoxycillin, Potassium Clavulanate & Lactic Acid Bacillus Tab | CHTC4419Mfg 2025-03 · Exp 2027-02 | 1) The sample declared as Not of Standard Quality in assay of Potassium Clavunalate e.q. to Clavulanic acid. 2) The sample does not conform to claim.Assay | SDTL, Kolkata, WBState lab | Feb 2026 |
| Ofloxacin & Ornidazole Tablets IP | OBT-2972Mfg 2024-04 · Exp 2026-03 | Dissolution TestDissolution | SDT&RL, BhubaneswarState lab | Jan 2026 |
| Cefixime, Azithromycin & Lactic Acid Bacillus Tablets | CHO-50003Mfg 2025-01 · Exp 2026-12 | Assay for Cefixime (as Anhydrous) & Azithromycin (as Anhydrous) onlyAssay | RDTL, Hubli, KarnatakaState lab | Jan 2026 |
| Cefidxime, Azithromycin & Lactic Acid Baciullus Tablets | MM-241491Mfg 2025-02 · Exp 2027-01 | Assay for Cefixime (as anhydrous) & Azithromycin (as Anhydrous)Assay | KarnatakaState lab | Aug 2025 |
| Amoxycillin & Potasium Clavulanate Tablets I.P. (IPHA CLAV-375) | NCP-151Mfg 2024-01 · Exp 2025-06 | Assay of Clavulanic AcidAssay | RDTL, GuwahatiCDSCO lab | Mar 2025 |
| CLAVPARK -LB 625mg (Amoxycillin , Potassium Clavulanate & Lactic Acid Bacillus Tab) | CHTJ426 0Mfg 2024-10 · Exp 2026-09 | Does not confirm to claimOther | SDTL KolkataState lab | Jan 2025 |
| Odeflox ? OZ (Ofloxacin & Ornidazole Tablets IP) | PR-202205Mfg 2022-02 · Exp 2024-01 | DissolutionDissolution | RDTL GuwahatiState lab | Apr 2023 |
| Azithromycin Tablets IP (BARLOCIN-250) | BL-12913Mfg 2021-12 · Exp 2023-11 | Assay & DissolutionAssay | RDTL GuwahatiState lab | Feb 2023 |
| Amoxycillin & Potassium Clavulanate Tablets IP CLAVPARK 625 | CH042014Mfg 2022-04 · Exp 2024-03 | Assay of Clavulanic Acid and Dissolution of Amoxycillin and Clavulanic AcidAssay | RDTL GuwahatiState lab | Feb 2023 |
| Secef - CV (Cefixime & Potassium Clavulanate Tablets) | TPP-014Mfg 2021-10 · Exp 2023-03 | Assay of Cefixime & Potassium ClavulanateAssay | CDL KolkataCDSCO lab | Sep 2022 |
| Moxiford Eye Drops (Moxifloxacin Eye Drops I.P.) | LHL-2692Mfg 2018-08 · Exp 2020-07 | Description & AssayAssay | CDL KolkataCDSCO lab | Oct 2019 |
| Ofloxacin Tablets I.P. (DRFLOX-200) | DRB-009Mfg 2017-07 · Exp 2019-06 | DissolutionDissolution | RDTL GuwahatiState lab | May 2019 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.